Darden Wealth Group’s AbbVie ABBV Stock Holding History

Darden Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Hold	4,775	–	–	0.53%	42
2025 Q4	$1.09M	Buy	4,775 +148	+3%	+$33.7K	0.53%	48
2025 Q3	$1.07M	Hold	4,627	–	–	0.56%	45
2025 Q2	$859K	Sell	4,627 -205	-4%	-$38.1K	0.52%	50
2025 Q1	$1.01M	Hold	4,832	–	–	0.78%	37
2024 Q4	$859K	Buy	4,832 +100	+2%	+$18.4K	0.58%	43
2024 Q3	$934K	Buy	4,732 +155	+3%	+$28.9K	0.67%	39
2024 Q2	$785K	Buy	4,577 +418	+10%	+$69.2K	0.47%	41
2024 Q1	$757K	Buy	4,159 +2,168	+109%	+$374K	0.59%	49
2023 Q4	$309K	Buy	+1,991	New	+$290K	0.3%	72

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Darden Wealth Group's ABBV Position: Q1 2026 in Review

Darden Wealth Group held its AbbVie (ABBV) position steady in Q1 2026 at 4,775 shares worth $1.04M. The position accounts for 0.53% of the portfolio, ranked #42.

Darden Wealth Group first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.09M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Darden Wealth Group held 4,775 shares of AbbVie worth $1.04M as of Q1 2026.
Darden Wealth Group left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.53% of Darden Wealth Group's portfolio in Q1 2026, its #42 holding.
Darden Wealth Group first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Darden Wealth Group's AbbVie position peaked at $1.09M in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Darden Wealth Group's 13F filing for Q1 2026, filed 8 May 2026.